Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4801
Magnachip Semiconductor
MX
$134M
| $14.7K | ﹤0.01% |
5,782
| – | – |
2024 Q3
5 quarters
|
|
|
TMQ
4802
Trilogy Metals
TMQ
$560M
| $14.4K | ﹤0.01% |
+3,342
| New | +$15.7K |
2025 Q4
0 quarters
|
|
|
NYXH
4803
Nyxoah
NYXH
$139M
| $14.3K | ﹤0.01% |
+3,098
| New | +$15.9K |
2025 Q4
0 quarters
|
|
|
HTZWW
4804
Hertz Global Holdings Warrants
HTZWW
$77.5M
| $14.2K | ﹤0.01% |
5,310
| – | – |
2022 Q1
15 quarters
|
|
|
TUYA
4805
Tuya Inc
TUYA
$1.04B
| $14.1K | ﹤0.01% |
6,691
| – | – |
2023 Q4
8 quarters
|
|
|
PMI
4806
Picard Medical
PMI
$13.5M
| $14.1K | ﹤0.01% |
161
+74
| +85% | +$17.4K |
2025 Q3
1 quarter
|
|
|
LPA
4807
Logistic Properties of the Americas
LPA
$94.8M
| $14K | ﹤0.01% |
5,133
+601
| +13% | +$2.02K |
2025 Q2
2 quarters
|
|
|
MENS
4808
Jyong Biotech
MENS
$162M
| $14K | ﹤0.01% |
+3,540
| New | +$125K |
2025 Q4
0 quarters
|
|
4809
UNIFI
UFI
$122M
| $13.5K | ﹤0.01% |
3,871
-6
| -0.2% | -$23 |
2016 Q2
38 quarters
|
|
4810
Verde Clean Fuels
VGAS
$24M
| $13.5K | ﹤0.01% |
6,560
+567
| +9% | +$1.65K |
2023 Q2
10 quarters
|
|
4811
Intercorp Financial Services
IFS
$5.86B
| $13.5K | ﹤0.01% |
319
+315
| +7,875% | +$13K |
2025 Q2
2 quarters
|
|
4812
State Street SPDR S&P International Dividend ETF
DWX
$509M
| $13.2K | ﹤0.01% |
300
| – | – |
2022 Q1
15 quarters
|
|
4813
Saga Communications
SGA
$53.9M
| $12.9K | ﹤0.01% |
1,129
| – | – |
2023 Q3
9 quarters
|
|
4814
Pliant Therapeutics
PLRX
$64.1M
| $12.9K | ﹤0.01% |
10,584
-358,972
| -97% | -$539K |
2022 Q1
15 quarters
|
|
|
ARAI
4815
Arrive AI Inc
ARAI
$11.2M
| $12.4K | ﹤0.01% |
4,729
-573
| -11% | -$2.4K |
2025 Q2
2 quarters
|
|
4816
Innovator US Equity Buffer ETF February
BFEB
$208M
| $12K | ﹤0.01% |
247
-1,443
| -85% | -$69K |
2024 Q3
5 quarters
|
|
|
ELVA
4817
Electrovaya
ELVA
$328M
| $12K | ﹤0.01% |
+1,520
| New | +$9.18K |
2025 Q4
0 quarters
|
|
4818
ALX Oncology
ALXO
$169M
| $11.9K | ﹤0.01% |
10,515
-52
| -0.5% | -$79 |
2022 Q1
15 quarters
|
|
4819
Delek Logistics
DKL
$3.17B
| $11.8K | ﹤0.01% |
265
-47
| -15% | -$2.11K |
2024 Q4
4 quarters
|
|
4820
KNOT Offshore Partners
KNOP
$366M
| $11.8K | ﹤0.01% |
1,141
-835
| -42% | -$8.09K |
2024 Q3
5 quarters
|
|
|
CVAC
4821
DELISTED
CureVac
CVAC
| $11.8K | ﹤0.01% |
2,609
-11,654
| -82% | -$59.7K |
2024 Q3
5 quarters
|
|
|
DLAG
4822
FT Vest U.S. Equity Dual Directional Buffer ETF - August
DLAG
$13.5M
| $11.7K | ﹤0.01% |
+374
| New | +$11.6K |
2025 Q4
0 quarters
|
|
4823
Cato Corp
CATO
$47.6M
| $11.5K | ﹤0.01% |
3,712
-35
| -0.9% | -$129 |
2016 Q1
39 quarters
|
|
|
DVS
4824
DELISTED
Dolly Varden Silver Corp
DVS
| $11.2K | ﹤0.01% |
+2,530
| New | +$11.1K |
2025 Q4
0 quarters
|
|
4825
CALL
Walmart Inc
WMT
$827B
| $11.1K | ﹤0.01% |
100
-78,300
| -100% | -$8.41M |
2023 Q4
8 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.